HEcoPerMed stands for “Healthcare- and pharma-economics in support of the International Consortium for Personalised Medicine – ICPerMed". The project responds to the demand for economic models that evaluate treatments made possible through innovations in personalised medicine. HEcoPerMed also seeks to identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations. HEcoPerMed goes beyond current assessment and payment models in order to serve the need of personalised medicine for more comprehensive cost-effectiveness estimates – incorporating patient and societal perspectives – and for sustainable affordability of cutting-edge health innovations.

Project launch

Project launch


The HEcoPerMed project started on 1.1.2019. The project aims to provide guidance on state-of-the-art health economic modelling, and on financing and payment strategies for personalised medicine in order to distinguish promises from reality. The project consortium consists of the AIT Austrian Institute of Technology, the German Aerospace Center EV, the Institute for Medical Technology Assessment, the Syreon Research Institute and the University of Oxford. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 824997.

Project Information

Project acronym:   HEcoPerMed
Project full title:     Health Economic Models for Personalised Medicine
Starting date:  01.01.2019
Duration:      36 months
Coordinator:         Dr Susanne Giesecke


Leave a Reply